KATELYN ZERBST: Open Payments
NPI 1396490843 · MOUNT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,509 in 68 payments from 17 companies in 2025. Trend: 2023 $882 · 2024 $1,006 · 2025 $2,509
Food & beverage: $1,759Consulting: $750
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $1,148 |
| Janssen Pharmaceuticals, Inc | 7 | $198 |
| Axsome Therapeutics, Inc. | 9 | $178 |
| E.R. Squibb & Sons, L.L.C. | 6 | $141 |
| Otsuka America Pharmaceutical, Inc. | 2 | $138 |
| Vanda Pharmaceuticals Inc. | 5 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| Corium, LLC | 3 | $89 |
| Lundbeck LLC | 3 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $83 |
Products named: SPRAVATO, Auvelity, VRAYLAR, COBENFY, ABILIFY ASIMTUFII, HETLIOZ, CAPLYTA, QULIPTA.
Industry payments across SC — which companies pay providers there.
